Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, September 16 at 2:00 PM EDT

Register Free →

This Combined Synopsis/Solicitation opportunity from Department Of Health And Human Services was posted on July 24, 2026. The submission period has ended. Browse the details below for market research, or find similar active opportunities.

Procurement of lateral flow (LFA) strips for the rapid HIV nucleic acid diagnostic test

Closed
75D30126Q79099Federal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

Active Opportunities Like This One

NAICS: 541714
New
Federal
Human Hindbrain Organoid Functional Assay Services.
Solicitation # RFQ_CDR-2026-135968
The U.S. Food and Drug Administration, through the Center for Drug Evaluation and Research, intends to award a sole-source, firm-fixed-price purchase order to OrganoTherapeutics SARL for human iPSC-derived hindbrain organoid functional assay services. This acquisition, conducted under FAR Part 12 as a commercial service, aims to support in vitro research on drug-induced effects on respiratory-relevant neural circuits. The scope of work includes the provision of human hindbrain organoids and associated culture materials, with twelve scheduled deliveries to the FDA White Oak Campus in Silver Spring, Maryland. The first delivery will consist of 96 organoids, followed by eleven subsequent deliveries of 48 organoids each. The contractor will perform functional characterization at its own laboratory using three-dimensional multi-electrode array technology to assess electrophysiological responses to FDA-identified drug and reversal-agent combinations. Key deliverables include the raw and analyzed data, analysis files, and comprehensive study reports. The anticipated period of performance is 18 months from the date of award. Award will be based on best value, with technical capability and past performance weighted more heavily than price. All invoicing must be processed electronically through the U.S. Department of Treasury's Invoice Processing Platform.
FDA Office Of Acq Grant Svcs

POSTED

1 day ago

DEADLINE

in 5 days
NAICS: 541714
New
Federal
Hypoxia Chamber Services
Solicitation # 80JSC026Q0008
NASA Johnson Space Center is soliciting combined synopsis and request for quotations under solicitation 80JSC026Q0008 for Hypoxia Chamber Services to support the Artemis Program. The objective is to investigate the physiological, cognitive, and clinical effects of mild hypobaric hypoxia through two 7-day test protocols involving continuous habitation for six subjects at air equivalent altitudes of 7,000 and 9,500 feet. The scope of work encompasses the provision of infrastructure, personnel, training, materials, and operational support. The contract is structured as a firm fixed price agreement with a base period from September 15, 2026, to September 30, 2027, and multiple option periods extending through March 1, 2030. The acquisition is open to all responsible sources under NAICS code 541714, with a size standard of 1,000 employees. Evaluation is based on a trade-off process where technical acceptability and past performance are significantly more important than price. Proposals must be submitted via email to the designated points of contact by October 1, 2026, following an extension granted in Amendment 0004. Key requirements include the submission of FAR 52.212-3 representations and certifications and adherence to specific submission criteria regarding team qualifications and risk assessment. The contract also incorporates strict guidelines regarding the protection of sensitive information and restrictions on funding activities with China.
NASA Johnson Space Center

POSTED

2 days ago

DEADLINE

in 19 days
NAICS: 541714
New
Federal
Hypobaric Chamber Pilot Studies
Solicitation # 80JSC026Q0006
NASA Johnson Space Center is soliciting quotes under solicitation 80JSC026Q0006 for pilot hypobaric chamber testing facilities to support decompression sickness research. The primary objective is to validate non-NASA resources for safe prebreathe procedures and extravehicular activity to support Artemis mission planning. The base requirement consists of three test days, with a minimum of two subjects per day, collecting and recording data according to research protocols. The contract also includes six optional work items, including additional test days, inflight-like treatment preparation, elevated metabolic rate testing, pharmaceutical-enhanced prebreathe, and body temperature studies. The base period of performance runs from September 1, 2026, to September 30, 2027, with various option periods extending through March or September 2029. This is a small business set-aside acquisition under NAICS code 541714. Awards will be made based on a trade-off analysis where technical acceptability and past performance are significantly more important than price. Technical evaluation focuses on facility capabilities, medical support, team expertise, and the proposed schedule for subject throughput. Offerors must provide a price quotation using the provided pricing sheet, and quotes must remain valid for at least 90 days. Following several amendments, the final deadline for the submission of offers is October 1, 2026, at 1:00 p.m. Central Time. All submissions must be sent electronically to the designated points of contact.
NASA Johnson Space Center

POSTED

2 days ago

DEADLINE

in 19 days

AI Contract Overview

Show more

The Centers for Disease Control and Prevention is soliciting bids for the procurement of 4,000 lateral flow strips intended for use in a rapid HIV nucleic acid diagnostic test under a firm-fixed-price contract, issued as a Request for Quote in accordance with FAR Subpart 12 for commercial items. The solicitation number is 75D30126Q79099, with a performance period of August 1, 2026, to December 31, 2026, and an option to extend services for up to six additional months. Proposals must be submitted electronically to Eugene Gutierrez at zvm0@cdc.gov no later than 3:00 P.M. Eastern Standard Time on Friday, July 24, 2026, with no telephonic or paper submissions accepted. The place of performance is the CDC facility at 1600 Clifton Road, Building 17, Atlanta, GA 30329-4018. Offerors must be registered in the System for Award Management at the time of submission and are required to comply with all applicable FAR clauses, including 52.212-1 and 52.212-4, along with deviations such as those addressing trafficking in persons, contractor employee whistleblower rights, sustainable products and services, Buy American Act alternatives for Israeli and Korean end products, and prohibitions on unauthorized information sharing. Technical evaluation is the predominant factor in award, emphasizing experience with biomedical devices, FDA approval processes, and prior work with lateral flow technology, with price considered secondary. The contractor must deliver 200 prototype strips and 4,000 final units meeting stringent performance standards: ≤0.5% false positive rate and ≤1% false negative rate using CDC’s LAMP reaction, and must ensure full compatibility with CDC’s mass production protocols. All deliverables must conform to Section 508 accessibility requirements, including WCAG 2.0 Level AA, and vendors must provide a Voluntary Product Accessibility Template or HHS conformance checklist. The contract imposes strict security and confidentiality obligations, including mandatory non-disclosure agreements for all employees accessing sensitive information, identification protocols to distinguish contractor personnel from government staff, and prohibitions against retaining or disseminating federal records or Privacy Act data. Subcontractors must be bound by the same requirements, and all payments must be processed via the Treasury’s Invoice Processing Platform using an ACH Vendor Enrollment

General Info

CDC seeks firm-fixed-price quotes for HIV LFA strips from August to December 2026, with submissions due July 24, 2026.

Agency

Department Of Health And Human Services → CDC Office Of Acquisition ServicesView Agency

Contract Value

$170,680

NAICS

541714 - Research and Development in Biotechnology (except Nanobiotechnology)View NAICS

Place of Performance

Atlanta, GA, 30329, USA

Set-Aside

NONE

Awardee

BEACON SCIENTIFIC INCView Profile

Award Issued Date

Documents

(4)

RFQ 75D301-26-Q-79099 Revised - Lateral Flow Strips for Rapid HIV NAT

PDFrfq

RFQ 75D301-26-Q-79099 for Lateral Flow Strips Procurement

PDFrfq

Solicitation 75D301-26-Q-79099 Questions and Answers Final

PDFq-and-a

Amendment 00001 to RFP 75D301-26-Q-79099

PDFamendment

AI Contract Breakdown

Uniform Contract Format

Sign up to view the full breakdown with detailed analysis of each section.

Timeline

1 update
PhaseClosed
Posted

Combined Synopsis

Amendment 1

Contract was updated

Response Deadline

Deadline has passed

Submission Closed

Find active opportunities like this

Start your free trial to discover similar active contracts, track opportunities, and build proposals with AI assistance.

Organization & Contact Information

Show more
AgencyDepartment Of Health And Human Services → CDC Office Of Acquisition Services
Contacts2 people available
OfficeATLANTA, GA, 30333, USA
Organization / Agency
Department Of Health And Human Services → CDC Office Of Acquisition Services
View Agency Profile
Office AddressATLANTA, GA, 30333, USA

Full Description

Show more

This is a combined synopsis/solicitation for commercial items prepared in accordance with the format in Federal Acquisition Requirements (FAR) Subpart 12.202, as supplemented with additional information included in this notice. This announcement constitutes the only solicitation; proposals are being requested.


The solicitation number for this requirement is 75D30126Q79099 and is hereby issued as a Request for Quote (RFQ) using FAR Subpart 12 - Acquisition of Commercial Products and Commercial Services.


The Centers for Disease Control and Prevention intends to award a firm-fixed-price contract, see the attached RFQ for more details and instructions to offerors.  See the CLINS and FAR Clauses and Provisions associated with this combined synopsis / solicitation in the attached RFQ.


Period of Performance: 08/15/2026 – 01/15/2027

Questions due by COB Monday July 23, 2026

Place of Performance:  Center for Disease Contron and Prevention
                                      1600 Clifton Road, Building 17
                                       Atlanta, GA 30329-4018


The quote format is at the discretion of the offeror.


It is the offeror's responsibility to be familiar with the applicable clauses and provisions. Clauses and provisions may be accessed via the Internet at website FAR | Acquisition.GOV.


This acquisition is under North American Industry Classification System (NAICS) code 541714.  A Firm-Fixed Price purchase order will be issued in writing to the successful offeror. To be eligible to receive an award resulting from this solicitation, contractor must be registered in the System for Award Management (SAM) at the time of quote submission.


FAR Provision 52.212-1, Instructions to Offerors-Commercial Products and Commercial Services, applies to this acquisition.


FAR clause 52.212-4, Contract Terms and Conditions-Commercial Products and Commercial Services, applies to this acquisition.


No telephonic quotes will be processed. All responses must be received no later than 3:00 P.M., Eastern Standard Time on Friday, 29 July 2026. Please send any questions and quotes to Eugene Gutierrez, Contract Specialist at zvm0@cdc.gov.


Attachments:


1. RFQ – 75D30126Q79099
 

More opportunities from Department Of Health And Human Services → CDC Office Of Acquisition Services

Same awarding agency

NAICS: 813312
New
Federal
Non-Research Long-Term Care facility needed for the enrichment and socialization of Non-Human Primate colony
Solicitation # 75D30126Q79062
Solicitation 75D30126Q79062 is a request for a firm-fixed-price contract from the CDC Office of Acquisition Services to secure permanent housing and lifetime care for approximately 130 to 132 non-human primates. The objective is to transfer these animals into a GFAS-accredited sanctuary that prohibits research, breeding, the buying or selling of animals, and direct public contact. The scope of work includes transportation, intake examinations, quarantine, and ten years of comprehensive veterinary care, nutrition, and housing in naturalistic environments that support behavioral health and social group formation. The acquisition is not set aside for small businesses and falls under NAICS code 813312. Award selection will be based on a trade-off approach where technical criteria are significantly more important than price. Technical evaluation includes a Go/No Go screening for GFAS accreditation, followed by an assessment of facility information, staffing, animal management and safety plans, and past performance. All technical criteria must be rated as at least Acceptable for an offeror to be eligible for award. Following five amendments to incorporate Q&A and refine the solicitation, the final response deadline is September 14, 2026, at 5:00 PM EDT. Submissions must be electronic, consisting of a technical volume and a price volume. The contractor will assume sole custody and ownership of the animals, ensuring compliance with federal animal welfare standards, including those set by the USDA, APHIS, and AAALAC.
Environment, Conservation and Wildlife Organizations

POSTED

1 day ago

DEADLINE

in 2 days
View Details

Find Active Opportunities Like This

Get AI-powered intelligence on the opportunities still open

Every page of the solicitation package shredded into a compliance breakdown

AI-powered matching based on your capabilities and past performance

Competitor and incumbent history on the requirement

Automated alerts on amendments, Q&A deadlines, and award

Miguel
Hillary
Keith Deutsch
Christine

Join 650+ contractors already using CLEATUS